Evidence Hub

The Global Burden of Antimicrobial Resistance in Cancer Patients: A Systematic Review

Katana JS, Kiiru J

2026

18 participants

Abstract

Abstract Background Antimicrobial resistance (AMR) is a significant global threat to cancer care, especially for immunocompromised patients who face higher risks of infection-related morbidity and mortality. This systematic review compiles data on bacterial pathogens from cancer patients, their antimicrobial susceptibility patterns, and related clinical outcomes from six continents and 39 countries. Methods A comprehensive analysis of 50 peer-reviewed studies from 2014 to 2025 was conducted, selected from 8,294 records through rigorous PRISMA-guided screening. Studies included prospective cohorts (n = 15), retrospective cohorts (n = 18), cross-sectional analyses (n = 8), and systematic reviews (n = 9) examining bacterial infections in hematologic malignancies and solid-tumor malignancies. Results Gram-negative bacteria predominated across all continents except the Americas, where Gram-positive organisms were more prevalent. Escherichia coli was the most frequently isolated pathogen globally (12–50%), followed by Klebsiella pneumoniae (7.9–47.1%), Pseudomonas aeruginosa (3.2–29.5%), and Acinetobacter baumannii (4.8–18.2%). Carbapenem resistance reached alarming levels in Africa (36–57%), Asia (12.2–32.8%), and the Middle East (20–30%), while remaining relatively low in Europe (0.5-5%) and North America (2–5%). ESBL production was documented in 41–85% of Enterobacteriaceae in African studies compared to 2–15% in European cohorts. MRSA prevalence ranged from 9.7% (China) to 75%…

How strong is the evidence?

Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 18 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free